SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
----------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No: ______)*
INVERNESS MEDICAL INNOVATIONS, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class of Securities)
68859Q101
(CUSIP Number)
Michele F. Vaillant, Esq.
Sills Cummis Radin Tischman Epstein & Gross, P.A.
One Riverfront Plaza
Newark, New Jersey 07102
(973) 643-7000
(Name, address and telephone number of person
authorized to receive notices and communications)
August 8, 2003
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this schedule
is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the reminder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 (the "Act") or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following pages)
(Page 1 of 6 Pages)
CUSIP No. 68859Q101 13G Page 2 of 6 Pages
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Leroy Schecter
SS# 134-14-8271
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 620,345
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 159,100
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 620,345
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH 159,100
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
779,445
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
|_|
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.2%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 3 of 6 Pages
Schedule 13G
This Schedule 13G is filed by the undersigned to provide information
regarding the acquisition of certain shares of common stock, par value $0.001
per share (the "Common Stock"), of Inverness Medical Innovations, Inc. (the
"Issuer").
Item 1. (a) Name of Issuer
Inverness Medical Innovations, Inc.
(b) Address of Issuer's Principal Executive Offices
51 Sawyer Road, Suite 200
Waltham, Massachusetts 02453
Item 2. (a) Names of Persons Filing
Leroy Schecter (the "Reporting Person")
(b) Address of Principal Business Office
c/o American Strip Steel Corporation
55 Passaic Avenue
Kearny, New Jersey 07032
(c) Citizenship
United States
(d) Title of Class of Securities
Common Stock, par value $0.001 per share (the "Shares")
(e) CUSIP Number
68859Q101
Item 3. If this Statement is filed pursuant to Sections 240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a: Not
applicable
(a) |_| Broker or dealer registered under Section 15 of the
Act (15 U.S.C.78o).
(b) |_| Bank as defined in Section 3(a)(6) of the Act (15
U.S.C. 78c).
(c) |_| Insurance company as defined in Section 3(a)(19) of
the Act (15 U.S.C. 78c).
(d) |_| Investment company registered under Section 8 of the
Investment Company Act of 1940 (15 U.S.C, 80a-8).
(e) |_| An investment adviser in accordance with Section
240.13d-1(b)(1)(ii)(E).
Page 4 of 6 Pages
(f) |_| An employee benefit plan or endowment fund in
accordance with Section 240-13d-1(b)(1)(ii)(F).
(g) |_| A parent holding company or control person in
accordance with Section 240.13d-1(b)(1)(ii)(G).
(h) |_| A savings association as defined in Section 3(b) of
the Federal Deposit Insurance Act (12 U.S.C. 1813).
(i) |_| A church plan that is excluded from the definition
of an investment company under Section 3(C)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3).
(j) |_| Group, in accordance with Section 240.13d-1(b)(1)(ii)(J).
Item 4. Ownership
Provide the following information regarding the aggregate number and
percentage of the class of securities of the Issuer identified in
Item 1.
(a) Amount beneficially owned: 779,445
(b) Percent of class: 5.2%
(c) Number of shares as to which the person has:
(i) sole power to vote or direct the vote: 620,345
(ii) shared power to vote or to direct the vote: 159,100
(iii) sole power to dispose or to direct the disposition
of: 620,345
(iv) shared power to dispose or to direct the disposition of:
159,100*
*These shares are held of record by the Leroy Schecter Foundation, a
non-profit foundation of which Mr. Schecter is a director.
Item 5. Ownership of Five Percent or Less of a Class If this Statement is
being filed to report the fact that as of the date hereof the
reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following.
|_|
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
If any other person is known to have the right to receive or the
power to direct the receipt of dividends from, or the proceeds from
the sale of, such securities, a statement to that effect should be
included in response to this item and, if such interest relates to
more than five percent of the class, such person should be
identified. A listing of the shareholders of an investment company
registered under the Investment Company Act of 1940 or the
beneficiaries of an employee benefit plan, pension fund or endowment
fund is not required.
Not applicable.
Page 5 of 6 Pages
Item 7. Identification and Classification of Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
If a parent holding company or control person has filed this
schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under
Item 3(g) and attach an exhibit stating the identity and the Item 3
classification of the relevant subsidiary. If a parent holding
company or control person has filed this schedule pursuant to Rule
13d-1(c) or Rule 13d-1(d), attach an exhibit stating the
identification of the relevant subsidiary.
Not applicable.
Item 8. Identification and Classification of Members of the Group
If a group has filed this schedule pursuant to
240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an
exhibit stating the identity and Item 3 classification of each
member of the group. If a group has filed this schedule pursuant to
Rule 240.13d(c) or Rule 240.13d-1(d), attach an exhibit stating the
identity of each member of the group.
Not applicable.
Item 9. Notice of Dissolution of Group
Notice of dissolution of a group may be furnished as an exhibit
stating the date of the dissolution and that all further filings
with respect to transactions in the security reported will be filed,
if required, by members of the group, in their individual capacity.
Not applicable.
Item 10. Certification
By signing below, I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the Issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
Page 6 of 6 Pages
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: as of August 8, 2003
/s/ Leroy Schecter
---------------------
Leroy Schecter